Global Diabetes Market Research and Forecast, 2018-2023

Global Diabetes Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

INDORE, INDIA, March 14, 2018 /EINPresswire.com/ -- Orion Market Research (OMR), recently published a market research report on global diabetes market. According to OMR analysis, the global diabetes market is expected to grow at a CAGR of 7.6% during 2018-2023. The global diabetes market has witnessed a significant growth due to rising diabetic patients and development of new products into the market. The global diabetes market is segmented on the basis of type, drug class, devices, and geography. The report provides detailed and insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

The full report of Global Diabetes Market is available at https://www.omrglobal.com/industry-reports/diabetes-market/

Global diabetes market has been driven by the increasing prevalence of diabetes across the globe. According to WHO, the number of people with diabetes has increased from 108 million in 1980 to 422 million in 2014. The US alone spends 11% of its health expenditure on diabetes. India and China are the most affected economies with over 120 million patients suffering from diabetes. A majority of diabetes patients are either undiagnosed or lack the basic treatment. The impending unmet needs are forcing the companies and governments to provide basic needs for diabetes. R&D exploration will continue the growing trend in the diabetes market.

The global diabetes market on the basis of type is segmented as type1 diabetes, type2 diabetes, and gestational diabetes. Among these, type-1 diabetes is expected to hold the largest share. On the basis of drug class, the market is further bifurcated as alpha-glucosidase inhibitors, amylin analogs, antidiabetic combinations, dipeptidyl peptidase 4 inhibitors, incretin mimetics, insulin, meglitinides, non-sulfonylureas, SGLT-2 inhibitors, sulfonylureas, and thiazolidinedione. Moreover, on the basis of devices the market has been divided into blood glucose meters, blood glucose strips, insulin injection pens, insulin syringes, continuous glucose monitoring systems, insulin pumps, and lancets.

Geographically, the market is divided among four major regions – North America, Asia-Pacific (APAC), Europe, and Row (Rest of the world). North America is the leading geography followed by Europe and the Asia Pacific. The Asia Pacific has been expected to have the highest growth rate amongst the regions. The North American market has been driven by the high awareness, availability of reimbursements and high expenditure on healthcare. Asia Pacific market is driven by a high population of diabetic patients.

Companies profiled in the report:
• Abbott Laboratories Inc.
• Alere Inc.
• Ascensia Diabetes Care
• AstraZeneca Ltd.
• Bayer AG
• Becton, Dickinson and Company
• Biocon Ltd.
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Cellnovo Group
• Dexcom Inc.
• Diamyd Medical
• Eli Lily and Co.
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline
• Glenmark
• Johnson and Johnson
• Joslin Diabetes Center
• Lifescan
• Lupin Pharmaceuticals Ltd
• Mannkind Corporation
• Medtronic Plc
• Merck & Co.
• Micro Labs Ltd
• MSD Pharmaceuticals
• Novartis
• Novo-Nordisk
• Pfizer
• Prometheon Pharma, Llc
• Sanofi
• Smiths Medical
• Sun Pharmaceuticals Industries Ltd
• Takeda Pharmaceutical Ltd.
• Tandem Diabetes Care
• Thermalin, Inc
• USV Private Limited

For related reports please visit
http://www.omrglobal.com/reports-category/medical-devices/
https://www.omrglobal.com/reports-category/pharmaceuticals/

The report covers:

• Comprehensive research methodology of the diabetes market
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global diabetes market
• Insights about market determinants which are stimulating the global diabetes market
• Detailed and extensive market segments with regional distribution of forecasted revenues
• Extensive profiles and recent developments of market players

About Orion Market Research

Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, Company Profiling, consulting and other research-based services. OMR provides global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provides a 360-degree analysis of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here